American Society of Clinical Oncology

SHERPA: White

People

  1. O'Reilly
    O'Reilly
  2. Moore
    Moore
  3. Brennan
    Brennan
  4. Jarnagin
    Jarnagin
  5. Jasin
    Jasin
  6. Reidy
    Reidy
  7. Tang
    Tang
  8. Yu
    Yu
  9. Bhanot
    Bhanot
  10. Capanu
    Capanu

Groups

  1. Center for Pancreatic Cancer Research (8)
  2. Department of Medicine (8)
  3. Gastrointestinal Oncology Service (8)
  4. Sloan Kettering Institute Faculty (8)
  5. Solid Tumor Oncology Division (8)
  6. Breast Medicine Service (4)
  7. Cell Biology Program Faculty (3)
  8. GSK Faculty (3)
  9. Molecular Pharmacology and Chemistry Program Faculty (3)
  10. Biostatistics Service (2)
Search Within
  1. "Eileen O'Reilly"
  2. "Sloan Kettering Institute Faculty"
Formats
  1. Meeting Abstract (8)
Groups
  1. Center for Pancreatic Cancer Research (8)
  2. Department of Medicine (8)
  3. Gastrointestinal Oncology Service (8)
  4. Sloan Kettering Institute Faculty (8)
  5. Solid Tumor Oncology Division (8)
  6. Breast Medicine Service (4)

More Groups

People
  1. Eileen O'Reilly (8)
  2. Maeve Lowery (4)
  3. Laura Tang (3)
  4. Malcolm Moore (3)
  5. Mary Ellen Moynahan (3)
  6. David Klimstra (2)

More People

Years
  1. 2015 (3)
  2. 2014 (2)
  3. 2012 (1)
  4. 2011 (2)
Publications
  1. Journal of Clinical Oncology (8)

Results (8)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • nab-paclitaxel (nab-P) plus gemcitabine (Gem) vs Gem alone as adjuvant treatment for resected pancreatic cancer (PC) in a phase III trial (APACT)
    Meeting Abstract

    Tempero, M. A.; Cardin, D. B.; Biankin, A.; Goldstein, D.; Moore, M.; O'Reilly, E. M.; Philip, P. A.; Riess, H.; Macarulla, T.; Yung, L.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Pilot study of vemurafenib and panitumumab combination therapy in patients with BRAF V600E mutated metastatic colorectal cancer
    Meeting Abstract

    Yaeger, R. D.; Cercek, A.; O'Reilly, E. M.; Reidy, D. L.; Kemeny, N. E.; Wolinsky, T.; Gollub, M. J.; Lacouture, M. E.; Rosen, N.; Vakiani, E.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • Phase II trial of veliparib (V) in patients (pts) with previously treated BRCA or PALB2-mutated (mut) pancreas adenocarcinoma (PC)
    Meeting Abstract

    Lowery, M. A.; Kelsen, D. P.; Smith, S. C.; Moore, M.; Kindler, H. L.; Golan, T.; Segal, A.; Hollywood, E.; Maynard, H.; Capanu, M.; more...
    Journal of Clinical Oncology (2015)

    Fulltext@MSK | Save
  • APACT: A phase 3 randomized, open-label, multicenter trial evaluating the use of adjuvant nab-paclitaxel (nab-P) plus gemcitabine (G) versus G alone in patients (pts) with surgically resected ductal pancreatic adenocarcinoma (PDA)
    Meeting Abstract

    Tempero, M. A.; Cardin, D. B.; Biankin, A.; Goldstein, D.; Moore, M.; O'Reilly, E. M.; Philip, P. A.; Riess, H.; Macarulla, T.; Yung, L.; more...
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Evaluation of PARP inhibition as a platinum sparing strategy in BRCA2-deficient pancreatic tumors
    Meeting Abstract

    Lowery, M. A.; Lee, A.; Tobias, E.; Sung, P.; Bhanot, U.; Shakya, R.; Ludwig, T.; O'Reilly, E. M.; Jasin, M.; Moynahan, M. E.
    Journal of Clinical Oncology (2014)

    Fulltext@MSK | Save
  • Inhibition of poly (ADP-ribose) polymerase-1 (PARP-1) to increase radiosensitivity of human pancreatic cancer (PAC) cell lines proficient in homology-directed repair (HDR)
    Meeting Abstract

    Lowery, M. A.; Vanoli, F.; Yu, K. H.; Jasin, M.; O'Reilly, E. M.; Moynahan, M. E.
    Journal of Clinical Oncology (2012)

    Fulltext@MSK | Save
  • Evaluation of putative prognostic tissue biomarkers in pancreatic ductal adenocarcinoma
    Meeting Abstract

    Winter, J. M.; Tang, L. H.; Klimstra, D. S.; Brennan, M. F.; O'Reilly, E. M.; Jarnagin, W. R.; Allen, P. J.
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save
  • Phase II single-arm, single-institution trial of neoadjuvant gemcitabine and oxaliplatin treatment (NT) in patients (pts) with resectable pancreas adenocarcinoma (PC)
    Meeting Abstract

    O'Reilly, E. M.; Jarnagin, W. R.; Brennan, M. F.; Winston, C.; Tang, L. H.; Capanu, M.; Schattner, M.; Chen, L. Y.; DeMatteo, R. P.; DiMaio, C. J.; more...
    Journal of Clinical Oncology (2011)

    Fulltext@MSK | Save